- Weitere Titel
-
Diagnosis and treatment of polycythemia vera in the year 2015
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Deutsch
- Erschienen in
-
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015 ; volume:140 ; number:20 ; year:2015 ; pages:1501-1506
Deutsche medizinische Wochenschrift ; 140, Heft 20 (2015), 1501-1506
- Beteiligte Personen und Organisationen
- DOI
-
10.1055/s-0041-103336
- URN
-
urn:nbn:de:101:1-2019021311453359759347
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Ähnliche Objekte (12)
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Novel approaches in myelofibrosis
Molekular zielgerichtete Therapie der chronischen myeloischen Leukämie (CML)
Elucidating the complexity of the interferon alpha response and clonal heterogeneity in polycythemia vera patients using single-cell RNA sequencing
Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German study group for MPN bioregistry
Influence of the JAK2-V617F mutation on integrin-mediated adhesion to VCAM1 in murine and human cell lines in the context of classical Philadelphia-negative myeloproliferative neoplasms
Regulation of lipocalin 2 expression and function in BCR-ABL- and JAK2V617F-positive myeloproliferative neoplasms
An iPSC-derived myeloproliferative neoplasm model to study the role of CALR frameshift mutation zygosity and efficacy of telomerase inhibition
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
CRISPR/Cas9 mediated CXCL4 knockout in human iPS cells of polycythemia vera patient with JAK2 V617F mutation
A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis
A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Novel approaches in myelofibrosis
Molekular zielgerichtete Therapie der chronischen myeloischen Leukämie (CML)
Elucidating the complexity of the interferon alpha response and clonal heterogeneity in polycythemia vera patients using single-cell RNA sequencing
Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German study group for MPN bioregistry
Influence of the JAK2-V617F mutation on integrin-mediated adhesion to VCAM1 in murine and human cell lines in the context of classical Philadelphia-negative myeloproliferative neoplasms
Regulation of lipocalin 2 expression and function in BCR-ABL- and JAK2V617F-positive myeloproliferative neoplasms
An iPSC-derived myeloproliferative neoplasm model to study the role of CALR frameshift mutation zygosity and efficacy of telomerase inhibition
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
CRISPR/Cas9 mediated CXCL4 knockout in human iPS cells of polycythemia vera patient with JAK2 V617F mutation
A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis
A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Novel approaches in myelofibrosis
Molekular zielgerichtete Therapie der chronischen myeloischen Leukämie (CML)
Elucidating the complexity of the interferon alpha response and clonal heterogeneity in polycythemia vera patients using single-cell RNA sequencing
Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German study group for MPN bioregistry
Influence of the JAK2-V617F mutation on integrin-mediated adhesion to VCAM1 in murine and human cell lines in the context of classical Philadelphia-negative myeloproliferative neoplasms
Regulation of lipocalin 2 expression and function in BCR-ABL- and JAK2V617F-positive myeloproliferative neoplasms
An iPSC-derived myeloproliferative neoplasm model to study the role of CALR frameshift mutation zygosity and efficacy of telomerase inhibition
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
CRISPR/Cas9 mediated CXCL4 knockout in human iPS cells of polycythemia vera patient with JAK2 V617F mutation
A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis